Product Wiki · Recalls · EU Safety Gate (RAPEX)

Atomstack Lasergravierer A5 20 W — recall A11/00143/22

EU Safety Gate (RAPEX) · Germany · 2022-12-23 · Other risk levels

Machine-translated with AI — the facts come from the issuing authority’s own notice (linked on this page); this language version was translated automatically by an AI model and is not reviewed. The original-language notice is authoritative. How we use AI →
Agency
EU Safety Gate (RAPEX)
Recall identifier
A11/00143/22
Date of alert
2022-12-23
Country / jurisdiction
Germany
Authority classification
Other risk levels
Risk type
Damage to sight
Brand
Atomstack
Product category
Machinery
Product type
Laser engraving machine
Reported risk: The product is not equipped with protective casing, while the protective cover always leaves an open gap between the laser head cover and the workpiece when used; in addition, the product may be operated without the protective cover. Hence, the user’s eyes or a bystander may be exposed to the laser when this is reflected by the workpiece, resulting in damages to the eyes.
Action taken by the authority
Type of economic operator taking notified measure
Other
Category of measure
Removal of this product listing by the online marketplace
Date of entry into force
23/11/2022
Machine translation. This page was translated automatically from the English record we hold of the issuing authority’s notice. The English original is shown below and the authority’s own notice is linked above — both take precedence over this translation.

Product Name (original English): Atomstack Lasergravierer A5 20 W

Primary source: https://ec.europa.eu/safety-gate-alerts/screen/webReport/alertDetail/10007369

Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.

ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.